Tekla Healthcare Company Top Insiders

HQH Stock  USD 16.56  0.28  1.66%   
Tekla Healthcare's insiders are aggressively buying. The analysis of insiders' sentiment of trading Tekla Healthcare Investors stock suggests that almost all insiders are extremely bullish at this time. Tekla Healthcare employs about 13 people. The company is managed by 13 executives with a total tenure of roughly 123 years, averaging almost 9.0 years of service per executive, having 1.0 employees per reported executive.
Daniel Omstead  CEO
CEO and President Trustee, Member of Valuation Committee, CEO of Hambrecht and Quist Capital Management LLC and President - HQL and President of Hambrecht and Quist Capital Management LLC and Trustee of HQL
Oleg Pohotsky  Chairman
Independent Chairman of the Board of Trustees

Insider Sentiment 100

 Aggressively Buying

 
Selling
 
Buying

Latest Trades

2024-07-16Rose DimartinoAcquired 1000 @ 18.88View
2024-04-09Kathleen GoetzAcquired 525 @ 16.42View
Monitoring Tekla Healthcare's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

Tekla Healthcare Management Team Effectiveness

As of now, Tekla Healthcare's Return On Tangible Assets are decreasing as compared to previous years. The Tekla Healthcare's current Return On Assets is estimated to increase to 0.18, while Return On Capital Employed is projected to decrease to (0.0002). As of now, Tekla Healthcare's Non Currrent Assets Other are increasing as compared to previous years. The Tekla Healthcare's current Return On Tangible Assets is estimated to increase to 0.18, while Total Assets are projected to decrease to under 690.6 M. Tekla Healthcare's management efficiency ratios could be used to measure how well Tekla Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.
The current Common Stock Shares Outstanding is estimated to decrease to about 31.4 M. The Tekla Healthcare's current Net Loss is estimated to increase to about (166.1 M)

Tekla Healthcare Workforce Comparison

Tekla Healthcare Investors is currently under evaluation in number of employees category among its peers. The total workforce of Financials industry is currently estimated at about 168. Tekla Healthcare adds roughly 0.0 in number of employees claiming only tiny portion of equities under Financials industry.
The company has Net Profit Margin of 17.17 %, which may imply that it executes well on its competitive polices and has reasonable control over its expenses and variable costs. This is very large. In the same way, it shows Net Operating Margin of (0.03) %, which entails that for every $100 of revenue, it lost $0.03.

Tekla Healthcare Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Tekla Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Tekla Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Tekla Healthcare insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-06-01
1.0
1
1
 525.00 
 0.00 
2018-12-01
3.0
3
1
 15,682 
 0.00 
2014-06-01
1.0
6
6
 16,010 
 45,330 

Tekla Healthcare Notable Stakeholders

A Tekla Healthcare stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Tekla Healthcare often face trade-offs trying to please all of them. Tekla Healthcare's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Tekla Healthcare's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Daniel OmsteadCEO and President Trustee, Member of Valuation Committee, CEO of Hambrecht and Quist Capital Management LLC and President - HQL and President of Hambrecht and Quist Capital Management LLC and Trustee of HQLProfile
Oleg PohotskyIndependent Chairman of the Board of TrusteesProfile
Christopher MBASenior ManagerProfile
Dr MSPortfolio ManagerProfile
Lucinda StebbinsIndependent TrusteeProfile
Jeffrey BaileyIndependent TrusteeProfile
Rakesh JainIndependent TrusteeProfile
MBA MDVP MangProfile
Frank GentileSenior ManagerProfile
Thomas KentIndependent TrusteeProfile
William ReardonIndependent TrusteeProfile
Elizabeth NabelIndependent TrusteeProfile
Laura WoodwardChief Compliance Officer, Treasurer, SecretaryProfile

About Tekla Healthcare Management Performance

The success or failure of an entity such as Tekla Healthcare Inv often depends on how effective the management is. Tekla Healthcare management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Tekla management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Tekla management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.17  0.18 
Return On Assets 0.17  0.18 
Return On Equity 0.17  0.18 

Tekla Healthcare Workforce Analysis

Traditionally, organizations such as Tekla Healthcare use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Tekla Healthcare within its industry.

Tekla Healthcare Manpower Efficiency

Return on Tekla Healthcare Manpower

Revenue Per Employee828.4K
Revenue Per Executive828.4K
Net Income Per Employee14.2M
Net Income Per Executive14.2M

Complementary Tools for Tekla Stock analysis

When running Tekla Healthcare's price analysis, check to measure Tekla Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tekla Healthcare is operating at the current time. Most of Tekla Healthcare's value examination focuses on studying past and present price action to predict the probability of Tekla Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tekla Healthcare's price. Additionally, you may evaluate how the addition of Tekla Healthcare to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Transaction History
View history of all your transactions and understand their impact on performance